-+ 0.00%
-+ 0.00%
-+ 0.00%

Leerink Partners Maintains Outperform on Compugen, Lowers Price Target to $5

Benzinga·05/21/2026 14:38:56
Listen to the news
Leerink Partners maintains Compugen (NASDAQ:CGEN) with a Outperform and lowers the price target from $13 to $5.